Artificial proteins for displaying epitopes
US-2024353416-A1 · Oct 24, 2024 · US
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12N15/00 |
| Official title | Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) |
| Display label | Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) |
| Total patents | 1,183 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 86 |
| 2016 | 97 |
| 2017 | 124 |
| 2018 | 140 |
| 2019 | 141 |
| 2020 | 148 |
| 2021 | 134 |
| 2022 | 78 |
| 2023 | 80 |
| 2024 | 85 |
| 2025 | 50 |
| 2026 | 20 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Enzymes, micro-organisms and uses thereof, and a method of degrading hydrocarbon chains
US-2024228990-A9 · Jul 11, 2024 · US
Anti-Gliadin Antibodies
US-2024101651-A1 · Mar 28, 2024 · US
Methods for producing genetic modifications in a plant genome without incorporating a selectable transgene marker, and compositions thereof
US-2024084318-A1 · Mar 14, 2024 · US
Human cgrp receptor binding proteins
US-2015376286-A1 · Dec 31, 2015 · US
Biosynthetic proline/alanine random coil polypeptides and their uses
US-9221882-B2 · Dec 29, 2015 · US
Plant regulatory elements derived from medicago truncatula 3'UTR sequences, and uses thereof
US-9222099-B2 · Dec 29, 2015 · US
Fibronectin type iii domain proteins with enhanced solubility
US-2015368319-A1 · Dec 24, 2015 · US
Fucosylation-deficient cells
US-9206455-B2 · Dec 8, 2015 · US
Extraction solvents derived from oil for alcohol removal in extractive fermentation
US-9206448-B2 · Dec 8, 2015 · US
Plant regulatory sequence
US-2015337323-A1 · Nov 26, 2015 · US
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
US-9193796-B2 · Nov 24, 2015 · US
Split dose administration
US-9186372-B2 · Nov 17, 2015 · US
Anti-cancer adenoviruses
US-9187733-B2 · Nov 17, 2015 · US
Enone reductases
US-2015315613-A1 · Nov 5, 2015 · US
Production of alcohol esters and in situ product removal during alcohol fermentation
US-9175315-B2 · Nov 3, 2015 · US
Lipid acyltransferase proteins and methods of making them
US-9175271-B2 · Nov 3, 2015 · US
Methods of modulating cold sensory perception
US-2015307584-A1 · Oct 29, 2015 · US
Lipolytic enzyme variant with improved stability and polynucleotides encoding same
US-9163203-B2 · Oct 20, 2015 · US
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
US-2015291970-A1 · Oct 15, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C12N15/00?
- CPC C12N15/00 is the Cooperative Patent Classification code for “Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00).”
- How many patents are filed under CPC C12N15/00 (Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00))?
- Our database includes 1,183 publications tagged with this CPC code.
- Is patent activity under CPC C12N15/00 growing?
- Publication counts under this code: 85 in 2024 vs 50 in 2025 (latest complete years).